Terms: = Skin cancer AND CDX2, CDX3, 1045, ENSG00000165556, Q99626 AND Treatment
13 results:
1. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
Chorti E; Kanaki T; Zimmer L; Hadaschik E; Ugurel S; Gratsias E; Roesch A; Bonella F; Wessendorf TE; Wälscher J; Theegarten D; Schadendorf D; Livingstone E
Eur J Cancer; 2020 May; 131():18-26. PubMed ID: 32248071
[TBL] [Abstract] [Full Text] [Related]
2. Perianal Paget's disease: a clinicopathological and immunohistochemical study of 13 cases.
Liao X; Liu X; Fan X; Lai J; Zhang D
Diagn Pathol; 2020 Mar; 15(1):29. PubMed ID: 32209119
[TBL] [Abstract] [Full Text] [Related]
3. Cutaneous Metastasis of Adenocarcinoma of the Ampulla of Vater.
Fernandez-Flores A; Cassarino DS
Am J Dermatopathol; 2018 Oct; 40(10):758-761. PubMed ID: 29672360
[TBL] [Abstract] [Full Text] [Related]
4. Ileocecal adenocarcinoma with overexpression of P53 protein metastasized to the thenar muscle: report of a rare case and review of literature.
Yi C; Liu Z; Chu Y; Li S; Liu L; Li J; Yu X
Int J Clin Exp Pathol; 2015; 8(10):13546-51. PubMed ID: 26722571
[TBL] [Abstract] [Full Text] [Related]
5. Fine-needle aspiration cytology in a rare case of recurrent mucinous carcinoma of skin, displaying psammoma bodies on smears.
Rekhi B; Deodhar KK; Laskar SG; D'Cruz A
Diagn Cytopathol; 2015 Nov; 43(11):937-40. PubMed ID: 26302739
[TBL] [Abstract] [Full Text] [Related]
6. Specialized surveillance for individuals at high risk for melanoma: a cost analysis of a high-risk clinic.
Watts CG; Cust AE; Menzies SW; Coates E; Mann GJ; Morton RL
JAMA Dermatol; 2015 Feb; 151(2):178-86. PubMed ID: 25389712
[TBL] [Abstract] [Full Text] [Related]
7. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications.
Nash JW; Barrett TL; Kies M; Ross MI; Sneige N; Diwan AH; Lazar AJ
J Cutan Pathol; 2007 Jan; 34(1):49-54. PubMed ID: 17214855
[TBL] [Abstract] [Full Text] [Related]
9. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract] [Full Text] [Related]
10. [Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer].
Liu X; Song S; Guan Z; Wu S; Duan Y; Yu J; Yang L
Zhonghua Zhong Liu Za Zhi; 2002 Jan; 24(1):71-3. PubMed ID: 11977645
[TBL] [Abstract] [Full Text] [Related]
11. Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.
Jurincic-Winkler CD; von der Kammer H; Beuth J; Scheit KH; Klippel KF
Anticancer Res; 1996; 16(4A):2105-10. PubMed ID: 8712751
[TBL] [Abstract] [Full Text] [Related]
12. Report on the clinical effects of inadvertent radiation underdosage in 1045 patients.
Ash D; Bates T
Clin Oncol (R Coll Radiol); 1994; 6(4):214-26. PubMed ID: 7527247
[TBL] [Abstract] [Full Text] [Related]
13. treatment of unknown primary melanoma.
Velez A; Walsh D; Karakousis CP
Cancer; 1991 Dec; 68(12):2579-81. PubMed ID: 1933805
[TBL] [Abstract] [Full Text] [Related]
